Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 10:39 PM
NCT ID:
NCT03335267
Group ID:
EG000
Title:
CPX-351 (Cytarabine:Daunorubicin) Injection
Description:
Dosing for first induction: CPX-351
• CPX-351 at 100u/m2 will be administered on study days 1, 3 and 5
Dosing for second induction:
• CPX-351 at 100 u/m2 will be administered on days 1 and 3
Dosing for consolidation:
• CPX-351 at 65 u/m2 will be administered on days 1 and 3
CPX-351: Cytarabine:Daunorubicin Liposome Injection
Deaths Number Affected:
23
Deaths Number At Risk:
None
Serious Number Affected:
14
Serious Number At Risk:
30
Other Number Affected:
30
Other Number At Risk:
30
Study:
NCT03335267
Results Section:
NCT03335267
Adverse Events Module:
NCT03335267